Joshua Boger


Founder, Vertex Pharmaceuticals 

Dr. Boger founded Vertex Pharmaceuticals in 1989 and retired as Chief Executive Officer in 2009, staying on its board and chairing its Science & Technology Committee, until 2017. As founder of Vertex, he led the company’s efforts to develop science-based transformative medicines for over 20 years, transforming the firm into a successful global enterprise counting over 2,500 employees today. Vertex’s gripping story was profiled in two books: The Billion-Dollar Molecule (1995) and The Antidote (2014). Dr. Boger was also a pioneer in setting up alliances between Pharma and disease-focused foundations, which resulted in the commercialization of the first drug to address the genetic defect associated with Cystic Fibrosis.

He is the Chair of the Board of the Celebrity Series (Boston), Vice-Chair of the Alliance for Business Leadership, Vice-Chair of the Museum of Science (Boston), and serves on additional boards such as the Harvard Medical School Board of Fellows and the Science Advisory Council of WGBH.

Dr. Boger began his industry career at Merck and holds a Ph.D. degree in chemistry from Harvard University and a BA in chemistry and philosophy from Wesleyan University.